Latest News

Timely dermatomyositis diagnosis, treatment remain elusive


 

REPORTING FROM ICCLE 2018

– There was a median 1-year delay between the onset of symptoms and diagnosis of classic dermatomyositis, and a 17-month delay before diagnosis of amyopathic dermatomyositis, based on a review of 232 dermatomyositis patients seen at the University of Pennsylvania, Philadelphia.

Just 103 (44.4%) patients were diagnosed with dermatomyositis (DM) right out of the gate. Among the other 129, 48 (37.2%) were diagnosed with lupus, 38 (29.5%) with undifferentiated connective tissue disease, 10 (7.8%) went undiagnosed, and 33 (25.5%) were diagnosed with rosacea, psoriasis, rheumatoid arthritis, fibromyalgia, lichen planus, and a number of other conditions. By the time the DM diagnosis was finally confirmed, almost every patient had Gottron’s papules or sign.

Misdiagnosis of dermatomyositis (DM) is nothing new, but the study brings home just how common the problem is, even at a major academic medical institution.

One of the take homes is that clinicians should never forget about the possibility of DM even when patients are diagnosed with other autoimmune diseases, and remain vigilant for erythema on the lateral thighs or nasolabial fold, Gottron’s papules, and other diagnostic giveaways, the researchers said.

Basil Patel, MD, University of Pennsylvania, Philadelphia. M. Alexander Otto/MDedge News

Dr. Basil Patel

“Biopsies for lupus and DM can be essentially identical,” with interface dermatitis and dermal mucin found in both. “We see a lot of patients misdiagnosed with” cutaneous or systemic lupus, said investigator Basil Patel, MD, a research fellow at the university.

Interface dermatitis, in particular, can’t be relied on to differentiate the conditions. A better option is checking for lupus bands and membrane attack complexes on direct immunofluorescence.

There’s also just not enough awareness that dermatomyositis can present without the classic muscle symptoms and findings, i.e. clinically amyopathic DM. While 49 of 120 patients with classic dermatomyositis (40.8%) were misdiagnosed or undiagnosed in the study, the number rose to 80 of 112 (71.4%) among amyopathic patients.

Pages

Recommended Reading

VIDEO: Let clinical scenario, not imaging, guide sarcoidosis treatment
MDedge Rheumatology
VIDEO: Researchers seek end to early corticosteroid use in AAV
MDedge Rheumatology
VIDEO: Skin exam crucial in rheumatic diseases, expert says
MDedge Rheumatology
VIDEO: Characteristic flora define intestinal microbiome in scleroderma
MDedge Rheumatology
VIDEO: Calming microglia might control fibromyalgia
MDedge Rheumatology
Newer IgG4 testing proving effective in assessing patients
MDedge Rheumatology
New agents may bring hope for SLE patients
MDedge Rheumatology
Caution crucial for stem cell transplant in scleroderma, despite potential interest
MDedge Rheumatology
Don’t trust interface dermatitis to diagnose dermatomyositis
MDedge Rheumatology
Median time to progression from discoid to systemic lupus may be less than a year
MDedge Rheumatology